Co-Diagnostics Inc

NASDAQ:CODXUnited States

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Contact Information

Headquarters

4049 S Highland DrSALT LAKE CITY, UT, United States 84124-1664

Phone

801-278-9769

Fax

---

Executives

Chairman of the Board, Chief Executive Officer

Dwight Egan

President

Richard Abbott

Chief Financial Officer, Company Secretary

Brian Brown

Chief Operations Officer

David Nielsen

Chief Technology Officer

Christopher Thurston